Vanguard Group Inc Brickell Biotech, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
N/A
-4,719 Reduced 16.99%
23,060 $40,000
Q3 2022

Nov 14, 2022
BUY
$1.72 - $4.41 $47,779 - $122,505
27,779 New
27,779 $50,000

Others Institutions Holding BBI

# of Institutions
1
Shares Held
65K
Call Options Held
0
Put Options Held
0
View Full List

About Brickell Biotech, Inc.

BBI Quotes by TradingView
  • Ticker BBI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,873,960
  • Market Cap $6.75M
  • Description
  • Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary ...
More about BBI
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email